Merck

Ebola Bundibugyo outbreak spreads across Africa and Europe

29 clusters · 803 sources · last updated about 15 hours ago

Latest: Democratic Republic of the Congo Ebola outbreak exceeds 5,000 deaths

The Bundibugyo Ebola outbreak in the Democratic Republic of Congo (DRC) has become the deadliest in the nation’s history and the second largest ever recorded globally. By late October 2026, the epidemic surpassed 10,350

AIFA rare disease treatment approvals in Italy

2 clusters · 22 sources · last updated 2 days ago

Latest: Italy approves reimbursement for mirdametinib to treat neurofibromatosis type 1

The Italian Medicines Agency (AIFA) has expanded the reimbursement of several specialized therapies through the National Health Service. On October 29, 2026, AIFA approved reimbursement for beremagene geperpavec (Vyjuv

ESMO 2026 oncology congress developments

4 clusters · 89 sources · last updated 2 days ago

Latest: ESMO 2026: New cancer therapies presented in Madrid

The European Society for Medical Oncology (ESMO) 2026 congress in Madrid presented various phase 3 clinical trial results across multiple cancer types. Initial reports highlighted advancements in melanoma, where combini

European pharmaceutical industry economic decline

2 clusters · 2 sources · last updated 2 days ago

Latest: European pharmaceutical industry faces production declines

The pharmaceutical sectors in Germany and Austria are facing significant declines in production and revenue. In Germany, the Association of Research-Based Pharmaceutical Manufacturers (VFA) forecasts a 2.2 percent drop i

US stock market volatility and rising Treasury yields

21 clusters · 229 sources · last updated 3 days ago

Latest: S&P 500 market trends and algorithmic forecasting

By late October 2026, the S&P 500 has navigated significant volatility driven by high valuations and concerns over market concentration. While the index maintained a year-to-date increase of approximately 12% to 13.8%, a

Merck financial performance and product updates

2 clusters · 5 sources · last updated 4 days ago

Latest: Merck reports strong third-quarter results and raises profit outlook

Merck reported strong third-quarter 2026 financial results, exceeding analyst expectations with revenue of $18.09 billion, a 4.7% increase year-on-year. Due to this performance, the company raised its full-year revenue g

DRC Ebola outbreak expands and impacts healthcare workers

439 clusters · 3350 sources · last updated 5 days ago

Latest: Belgium deploys mobile laboratory to Congo to combat Ebola outbreak

The Bundibugyo-strain Ebola outbreak in the Democratic Republic of Congo (DRC) continues to escalate, marking one of the deadliest epidemics in the country’s history. As of late October 2026, confirmed cases have surpass

Moderna and Merck melanoma vaccine clinical trials

19 clusters · 558 sources · last updated 5 days ago

Latest: BioNTech and Moderna face mixed clinical and market outlooks

Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (V940), an experimental personalized mRNA cancer vaccine. The INTerpath-001 trial, which administered the vaccine alon

mRNA technology and personalized cancer vaccine research

3 clusters · 117 sources · last updated 6 days ago

Latest: Merck and Moderna mRNA vaccine reduces melanoma recurrence risk

Recent medical research highlights significant progress in using messenger RNA (mRNA) technology to develop personalized cancer vaccines. These vaccines utilize a patient’s specific tumor mutations or neoantigens to trai

UAE healthcare development and global health initiatives

2 clusters · 4 sources · last updated 6 days ago

Latest: Healthcare providers in UAE and Saudi Arabia advance digital technology adoption

The United Arab Emirates is expanding its healthcare footprint through both specialized research and digital transformation. The Department of Health – Abu Dhabi has partnered with Merck to establish a Fertility and IVF

Merck industrial expansions in South Korea

2 clusters · 7 sources · last updated 6 days ago

Latest: Merck opens €300 million bioprocessing hub in Daejeon, South Korea

Merck has expanded its industrial footprint in South Korea through two major facility openings in October 2026. In Eumseong, Merck Electronics inaugurated a production facility dedicated to manufacturing molybdenum prec

Dengue prevention and regional strategy in the Americas

10 clusters · 70 sources · last updated 7 days ago

Latest: Latin American regions intensify dengue prevention measures

Health authorities and experts in Latin America continue to focus on mosquito control and prevention strategies to combat dengue, chikungunya, and zika viruses. Following previous efforts in Argentina, Paraguay, Colombia

Hong Kong financial and technology sector events

2 clusters · 14 sources · last updated 10 days ago

Latest: Merck and HKSTP partner to establish Merck Hong Kong Centre

Hong Kong is hosting several major industry events in late 2026 aimed at reinforcing its status as a global wealth and technology hub. In early October, the iFX Expo Hong Kong featured discussions on the shift of globa

Advances and challenges in mRNA and immunotherapy trials

11 clusters · 25 sources · last updated 12 days ago

Latest: Immunotherapy advancements show promise in treating colorectal and melanoma cancers

Cancer immunotherapy is evolving through personalized mRNA vaccines and cellular therapies. Recent breakthroughs include a platform generating T-cells from hematopoietic stem cells, which offers a ready-to-use alternativ

Germany wealth rankings for 2026

2 clusters · 6 sources · last updated 15 days ago

Latest: Germany's wealthiest individuals see asset growth despite economic weakness

The 2026 Manager Magazin ranking of the 500 wealthiest Germans identifies the Boehringer Ingelheim shareholder family as the wealthiest in the country, with an estimated fortune exceeding 66 billion euros. This marks a r

German public expenditure trends

3 clusters · 35 sources · last updated 16 days ago

Latest: Germany faces rising costs amid EU migration policy shifts

Recent reports highlight significant fiscal pressures within Germany across different sectors. Healthcare expenditures reached a record 528.5 billion euros in 2024, driven largely by demographic shifts where individuals

US pharmaceutical industry and Trump political rhetoric

2 clusters · 14 sources · last updated 19 days ago

Latest: Donald Trump pharmaceutical investments face scrutiny amid Medicare exemption claims

Donald Trump has utilized his political platform to address the opioid epidemic and pharmaceutical drug pricing, claiming his administration achieved the ‘greatest reduction’ in prescription costs. He has also used trade

BioNTech BNT113 clinical trial results

2 clusters · 6 sources · last updated 19 days ago

Latest: BioNTech BNT113 fails first clinical endpoint in head and neck cancer trial

BioNTech reported that its experimental mRNA cancer immunotherapy, BNT113, failed to meet the primary endpoint in a combined Phase 2/3 clinical trial known as AHEAD-MERIT. The study evaluated the combination of BNT113 an

South American textile sector downturn and restructuring

13 clusters · 87 sources · last updated 21 days ago

Latest: Argentina economy shows signs of industrial decline and falling consumption

The South American textile industry continues to face a regional squeeze characterized by shrinking output and job losses, alongside niche efforts toward sustainability. In Uruguay, clothing producers are struggling agai

Debbie Allen HIV advocacy for Black women

2 clusters · 4 sources · last updated 23 days ago

Latest: Debbie Allen advocates for HIV support networks for Black women

Debbie Allen is advocating for increased community support networks for Black women facing HIV, a demographic with diagnosis rates 12 times higher than White women. Her advocacy is informed by her professional experience

KRAS mutation cancer research and therapy development

2 clusters · 10 sources · last updated 23 days ago

Latest: KRAS targeted therapies face subtype efficacy challenges

Research into KRAS-targeted cancer therapies has focused on identifying the biological mechanisms behind drug resistance and the varying efficacy of treatments across different mutation subtypes. Initial studies using m

Barriers to rare cancer treatment and research

2 clusters · 4 sources · last updated 27 days ago

Latest: Medical experts highlight gaps in rare tumor and adolescent cancer care

Medical experts and advocacy groups are identifying systemic barriers to treatment and research for rare cancers and vulnerable patient populations. In the United States, insurance coverage gaps have been highlighted by

Kenya medical manufacturing and health system development

2 clusters · 6 sources · last updated 30 days ago

Latest: Kenya and Japan expand cooperation to strengthen health systems

Kenya is advancing its domestic medical manufacturing and healthcare infrastructure through private sector developments and international partnerships. Initial progress includes the inauguration of a new syringe manufac